HDSA invites uniQure to discuss the latest data from HD-GeneTRX studies of AMT-130

Join HDSA for a research webinar in which uniQure will present the latest update about their study of HD gene therapy AMT-130 in the ongoing HD-GeneTRX trial, and answer community questions. Speakers include Dr. Ed Wild, FRCP, Professor of Neurology at University College London, and Walid Abi-Saab, MD, Chief Medical Officer at uniQure.

[@Kaylathebutt]

🤞